AstraZeneca files bid for EU vaccine approval

Thank you for reading the news about AstraZeneca files bid for EU vaccine approval and now with the details

Jeddah – Yasmine El Tohamy – THE HAGUE: AstraZeneca and Oxford University have applied for authorization for their coronavirus vaccine in the European Union with a decision possible by Jan. 29, The European Medicines Agency said on Tuesday.
The jab would be the third available for the 27-nation EU after the Pfizer-BioNTech and Moderna drugs, as the bloc struggles to speed up the rollout.
“EMA has received an application for conditional marketing authorization for a COVID-19 vaccine developed by AstraZeneca and Oxford University,” the Amsterdam-based regulator said in a statement.
The EMA said its assessment would “proceed under an accelerated timeline.”
“An opinion on the marketing authorization could be issued by 29 January… provided that the data submitted on the quality, safety and efficacy of the vaccine are sufficiently robust and complete,” it said.
The EU and the EMA have been under pressure to speed up the approval of new vaccines against the virus, which has claimed the lives of more than 620,000 people across the continent.

These were the details of the news AstraZeneca files bid for EU vaccine approval for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Arab News and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.